In order to separately investigate anti-tumor functions of CD8+ and CD4+ T cells transduced with 19305DP-TCR, we polyclonally activated and retrovirally infected PBMC depleted of CD4+ or CD8+ cells to obtain TCR gene-transduced CD8+ or CD4+ T cells, respectively. The gene discussed is CD8A; the disease is neoplasm.